항글로블린법을 이용한 Panel Reactive Antibody 검사에서 교차반응군특이성의 동정 경험
Experience on Identification of Cross-Reactive Group Specificity Performed by Anti-human Globulin Panel Reactive Antibody Tests
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : Panel reactive antibody (PRA) is to screen and identify HLA antibody. Majority of antibody specificities in high-PRA are directed against cross reactive group (CREG). Thus, this study was to know the advantage of identifying CREG specificity and whether antibody specificities are changed according to CREG classification. Methods : HLA class I antibodies were identified from 159 sera from 108 patients in Asan Medical Center, who had shown more than 5% PRA by anti-human globulin (AHG)-complement-dependent cytotoxicity (CDC). Tail analysis-based computer program was developed to identify specificities, applying both Rodey (R-ABC) and Takemoto (T-ABC) classification. The results were also compared with those obtained when without CREG application (ABC). Results : Among 151 cases in which HLA specificities was identified, the frequency of CREG specificity was 22.5% in R-ABC and 27.2% in T-ABC. Eleven cases showed CREG specificities only in one classification. However, the individual antigen specificities in one hand were all included in the CREG identified in the other hand. CREG specificities in samples with PRA >50% (60%) were more frequently identified than those in samples with PRA ≤50% (9%) (in R-ABC, P<0.0001). Without applying CREG to interpretation, specificity was not identified in 9 cases. Conclusions : Application of CREG enhanced the rate of antibody identification. Antibody specificities of those cases where CREG specificities were different between Rodey and Takemoto classifications were almost the same when compared at the individual antigen level. Therefore, it was thought that it makes no difference to use any one of these two classifications in interpreting PRA. (Korean J Lab Med 2008;28:362-70)
참고문헌 (25)
- Reisner BS, "Comparison of an enzyme imm1. Keown PA. The highly sensitized patient: etiology, impact, and management", Transplant Proc, 19, pp.74~78 (1987)
- Braun WE., "The alloimmunized patient: monitoring and therapeutics", Am J Med Sci, 313, pp.279~282 (1997)
- Kerman RH, "Clinical relevance of anti-HLA antibodies pre and post transplant", Am J Med Sci, 313, pp.275~278 (1997)
- Fuller TC., "Monitoring HLA alloimmunization. Analysis of HLA alloantibodies in the serum of prospective transplant recipients", Clin Lab Med, 11, pp.551~570 (1991)
- Rodey GE, "Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods", Transplantation, 63, pp.885~893 (1997)
- Konoeda Y, "Public determinants of HLA indicated by pregnancy antibodies", Transplantation, 41, pp.253~259 (1986)
- Rodey GE, "Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients", Hum Immunol, 39, pp.272~280 (1994)
- Duquesnoy RJ, "Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation", Transplantation, 50, pp.427~437 (1990)
- Opelz G., "Kidney transplantation in sensitized patients", Transplant Proc, 19, pp.3737~3741 (1987)
- Bradley BA, "Council of Europe study of high sensitization in renal transplantation", Transplant Proc, 19, pp.3742~3743 (1987)
- Barama A, "Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants", Clin Transplant, 14, pp.212~217 (2000)
- Rodey GE, "Public epitopes and the antigenic structure of the HLA molecules", Crit Rev Immunol, 7, pp.229~267 (1987)
- Takemoto S, "HLA matching: a comparison of conventional and molecular approaches in: Clinical Transplants", pp.413~434 (1992), UCLA Tissue Typing Laboratory
- 차충환, "Human Leukocyte Antigen 항체특이성 동정을 위한 웹기반 프로그램 개발", 대한진단검사의학회지, 27(6), pp.458~463 (2007), 대한진단검사의학회
- Neefjes JJ, "Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glyco sylation on class I subunit association", Eur J Immunol, 18, pp.801~810 (1988)
- Neisig A, "Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction", J Immunol, 160, pp.171~179 (1998)
- Marsh SG, "Nomenclature for factors of the HLA system", Tissue Antigens, 65, pp.301~369 (2005)
- Opelz G., "Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment", Transplantation, 40, pp.240~243 (1985)
- Chapman JR, "Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody", Transplantation, 42, pp.91~93 (1986)
- Worthington JE, "Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome", Transplantation, 75, pp.1034~1040 (2003)
- Frohn C, "The effect of HLA-C matching on acute renal transplant rejection", Nephrol Dial Transplant, 16, pp.355~360 (2001)
- 황상현, "한국인의 HLA-A, -B, -C 대립유전자와 일배체형 분포", 대한진단검사의학회지, 24(6), pp.396~404 (2004), 대한진단검사의학회
- Park MH, "HLA haplotypes in Koreans based on 107 families", Tissue Antigens, 51, pp.347~355 (1998)
- Kim HS, "The distribution of HLA antigens and haplotypes in Koreans", Korean J Clin Pathol, 17, pp.1109~1123 (1997)
- 노은연, "DNA 형별검사에 의한 한국인의 HLA-A, -B, -DR 형별 및 일배체형의 분포", 대한진단검사의학회지, 23(6), pp.420~430 (2003), 대한진단검사의학회